Search Results for "Clindamycin Hydrochloride"

10:49 EST 20th December 2014 | BioPortfolio

Original Source: Clindamycin Hydrochloride [Physicians Total Care, Inc.]

Matching Channels

Syphilis

Syphilis is a sexually transmitted disease caused by the spirochetal bacteria Treponema pallidum subspecies pallidum. The primary route of transmission of syphilis is through sexual contact however ...

Matching News

Dr. Reddy’s launches OTC Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120mg extended-release tablets

Dr. Reddy’s Laboratories has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg, a bioequivalent generic version...

Dr. Reddy’s launches OTC Fexofenadine Hydrochloride 60 g and Pseudoephedrine Hydrochloride 120mg extended-release tablets

Dr. Reddy’s Laboratories has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg / 120 mg, a bioequivalent generic version...

FDA Approves Lannett's Oxycodone Hydrochloride Capsules 5 mg

Lannett Company today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone Hydrochloride Capsules, 5 mg...

Amneal Pharmaceuticals Announces Four New Generics

Clindamycin palmitate hydrochloride for oral solution, acyclovir ointment, atovaquone oral suspension, and oxycodone hydrochloride tablets add diversity to product selection ...

Dr. Reddy's Launches Generic Version Of Allegra-D 12 Hour

NEW DELHI (dpa-AFX) - Dr. Reddy's Laboratories (RDY) said Thursday it has launched its over-the-counter Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg ...

FDA approves tough-to-abuse formulation of oxycodone

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment fo...

Tough-to-abuse formulation of oxycodone approved

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment fo...

Targiniq ER Tough-to-Abuse Formulation of Oxycodone Approved

THURSDAY, July 24, 2014 -- Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock...

Matching PubMed Articles

Acute Psychotic Symptoms due to Benzydamine Hydrochloride Abuse with Alcohol.

Benzydamine hydrochloride is a locally acting nonsteroidal anti-inflammatory drug. Benzydamine hydrochloride overdose can cause stimulation of central nervous system, hallucinations, and psychosis. We...

Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.

Abstract The purpose of this research was to develop an orally disintegrating tablet (ODT) dosage form containing taste-masked beads of clindamycin HCl. Several formulation strategies were evaluated a...

Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination.

Development and validation of an HPLC method for tetracycline-related USP monographs.

A novel reversed-phase HPLC method was developed and validated for the assay of tetracycline hydrochloride and the limit of 4-epianhydrotetracycline hydrochloride impurity in tetracycline hydrochlorid...

An Aqueous Gel Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% for the Once-Daily Treatment of Moderate to Severe Acne Vulgaris.

To evaluate efficacy, safety, and tolerability of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 3.75% (clindamycin-BP 3.75%) aqueous gel in moderate to severe acne vulgaris. METH...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement